Home
/
Kezar Life Sciences, Inc.
/
Financials
/
Quarterly
Kezar Life Sciences, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Kezar Life Sciences, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2024
$0
Nov 12, 2024
Q3
2024
Sep 30, 2023
$7.00M
Nov 12, 2024
Q3
2023
Sep 30, 2022
$0
Nov 13, 2023
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($11.23M)
Nov 12, 2025
Q3
2025
Jun 30, 2025
($13.70M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($13.70M)
Aug 13, 2025
Q3
2025
Mar 31, 2025
($16.56M)
Nov 12, 2025
Q2
2025
Mar 31, 2025
($16.56M)
Aug 13, 2025
Q1
2025
Mar 31, 2025
($16.56M)
May 13, 2025
Q3
2025
Sep 30, 2024
($20.31M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($21.55M)
Aug 13, 2025
Q3
2025
Jun 30, 2024
($21.55M)
Nov 12, 2025
Q2
2025
Mar 31, 2024
($21.66M)
Aug 13, 2025
Q1
2025
Mar 31, 2024
($21.66M)
May 13, 2025
Q3
2025
Mar 31, 2024
($21.66M)
Nov 12, 2025
Q3
2024
Sep 30, 2023
($23.10M)
Nov 12, 2024
Q3
2024
Jun 30, 2023
($24.31M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($24.31M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($22.20M)
May 9, 2024
Q2
2024
Mar 31, 2023
($22.20M)
Aug 13, 2024
Q3
2024
Mar 31, 2023
($22.20M)
Nov 12, 2024
Q3
2023
Sep 30, 2022
($17.85M)
Nov 13, 2023
Q3
2023
Jun 30, 2022
($16.19M)
Nov 13, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($11.72M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($14.60M)
Aug 13, 2025
Q1
2025
Mar 31, 2025
($17.63M)
May 13, 2025
Q3
2025
Sep 30, 2024
($21.95M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($23.38M)
Aug 13, 2025
Q1
2025
Mar 31, 2024
($23.71M)
May 13, 2025
Q3
2024
Sep 30, 2023
($25.53M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($26.78M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($24.52M)
May 9, 2024
Q3
2023
Sep 30, 2022
($18.93M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($16.32M)
Aug 10, 2023
Q1
2023
Mar 31, 2022
($15.88M)
May 11, 2023
Q3
2022
Sep 30, 2021
($14.50M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($13.01M)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($13.05M)
May 12, 2022
Q3
2021
Sep 30, 2020
($11.55M)
Nov 9, 2021
Q2
2021
Jun 30, 2020
($9.85M)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($10.48M)
May 12, 2021
Q3
2020
Sep 30, 2019
($9.68M)
Nov 5, 2020
Q2
2020
Jun 30, 2019
($9.36M)
Aug 6, 2020